Business Paid
NanoVelos to start clinical tests of cancer drug in 2020
20:24
Biotechnological company NanoVelos belonging to NanoGroup intends to start production of a cancer drug in the GMP standard at the beginning of 2020, enabling it to be initially administered to animals in the GLP standard and ultimately to people in clinical trials, NanoGroup said in a press release.“We would like to start clinical trials next year,” Marek Borzestowski…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
